PolyPid to Report Second Quarter 2022 Financial Results and Operational Highlights on August 10, 2022

Lab tools
July 2022

PETACH TIKVA, Israel, July 27, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2022 financial results and operational highlights before the

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon